SCHEMBL17171964

SCHEMBL17171964

CC(C)(C)C(O)(c1cncnc1)c1ccc(-c2ccc(OCC(F)(F)F)cc2)cc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CACNA1B Q00975 1/20 0.44
▸ CYP3A4 P08684 4/20 0.40
▸ CYP2C9 P11712 3/20 0.40
▸ CYP2C19 P33261 3/20 0.40
▸ CYP11B1 P15538 2/20 0.38
▸ CYP11B2 P19099 2/20 0.38
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ DGAT1 O75907 2/20 0.36
▸ AAK1 Q2M2I8 1/20 0.35
▸ SCN5A Q14524 1/20 0.35
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ RXRG P48443 1/20 0.34
▸ CYP17A1 P05093 1/20 0.34
▸ BACE1 P56817 2/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ FAAH O00519 1/20 0.33
▸ TRPV3 Q8NET8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19239204 0.91 CACNA1B (0.43) CACNA1BCYP3A4CYP2C9CYP2C19CYP11B1
SCHEMBL17171880 0.90 CYP3A4 (0.45) CACNA1BCYP3A4CYP2C9CYP2C19CYP11B1
SCHEMBL17171885 0.89 CACNA1B (0.43) CACNA1BCYP3A4CYP2C9CYP2C19CYP11B1
SCHEMBL17159528 0.86 SCN5A (0.43) CYP3A4CYP2C9CYP2C19CYP11B1CYP11B2
SCHEMBL17171868 0.86 CACNA1B (0.44) CACNA1BCYP3A4CYP2C9CYP2C19DGAT1
SCHEMBL17171962 0.84 CYP11B1 (0.38) CYP3A4CYP11B1CYP11B2AAK1SCN5A
SCHEMBL17157474 0.82 CYP3A4 (0.45) CACNA1BCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL17171966 0.81 PIK3CA (0.39) CYP3A4CYP2C9CYP2C19KCNH2TRPV3
SCHEMBL17171963 0.80 CYP19A1 (0.33) CYP11B1CYP11B2RXRARXRBRXRG
SCHEMBL17171968 0.79 AR (0.35) CYP3A4CYP11B1CYP11B2RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663491-B2 Metalloenzyme inhibitor compounds as fungicides DOW AGROSCIENCES LLC (US) 2017-05-30 — — US disclosed
US-9663491-B2 Metalloenzyme inhibitor compounds as fungicides DOW AGROSCIENCES LLC (US) 2017-05-30 — — US disclosed
WO-2015160664-A1 METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES DOW AGROSCIENCES LLC (US) 2015-10-22 — — WO disclosed
US-20150291557-A1 METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES DOW AGROSCIENCES LLC 2015-10-15 — — US disclosed
US-20150291557-A1 METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES DOW AGROSCIENCES LLC 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291557-A1 METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES GPX1, POR, MGAM CACNA1B 1415/4885CYP3A4 89/4885CYP2C9 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback